• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化中的血管综合征

Vascular syndromes in liver cirrhosis.

作者信息

Shenoda Botros, Boselli Joseph

机构信息

Department of Medicine, Drexel University College of Medicine, Philadelphia, PA, 19102, USA.

Drexel Internal Medicine, 205 N. Broad Street, Philadelphia, 19107, USA.

出版信息

Clin J Gastroenterol. 2019 Oct;12(5):387-397. doi: 10.1007/s12328-019-00956-0. Epub 2019 Apr 12.

DOI:10.1007/s12328-019-00956-0
PMID:30980261
Abstract

Liver cirrhosis is associated with multiple vascular syndromes affecting almost all body systems. Many of these syndromes are directly related to impaired liver function and sometimes reversible after liver transplantation while others arise secondary to portal hypertension and ascites. Altered expression of angiogenic and vasoactive compounds (most importantly nitric oxide), endothelial dysfunction, dysregulated neurohormonal control, and systemic inflammatory state play differential roles in mediating homeostatic instability and abnormal vasogenic response. Important vascular features encountered in liver disease include portal hypertension, splanchnic overflow, abnormal angiogenesis and shunts, portopulmonary syndrome, hepatopulmonary syndrome, and systemic hyperdynamic circulation. Redistribution of effective circulatory volume deviating from vital organs and pooling in splanchnic circulation is also encountered in liver patients which may lead to devastating outcomes as hepatorenal syndrome. Etiologically, vascular syndromes are not isolated phenomena and vascular dysfunction in one system may lead to the development of another in a different system. This review focuses on understanding the pathophysiological factors underlying vascular syndromes related to chronic liver disease and the potential links among them. Many of these syndromes are associated with high mortality, thus it is crucial to look for early biomarkers for these syndromes and develop novel preventive and therapeutic strategies.

摘要

肝硬化与多种血管综合征相关,这些综合征几乎影响身体的所有系统。其中许多综合征与肝功能受损直接相关,有时在肝移植后可逆转,而其他综合征则继发于门静脉高压和腹水。血管生成和血管活性化合物(最重要的是一氧化氮)表达改变、内皮功能障碍、神经激素控制失调以及全身炎症状态在介导体内稳态不稳定和异常血管生成反应中发挥着不同作用。肝病中遇到的重要血管特征包括门静脉高压、内脏血流增多、异常血管生成和分流、门肺综合征、肝肺综合征以及全身高动力循环。肝病患者还会出现有效循环血容量从重要器官重新分布并在内脏循环中积聚的情况,这可能导致诸如肝肾综合征等灾难性后果。从病因学角度来看,血管综合征并非孤立现象,一个系统的血管功能障碍可能导致另一个不同系统中血管综合征的发生。本综述着重于理解与慢性肝病相关的血管综合征背后的病理生理因素以及它们之间的潜在联系。这些综合征中的许多都与高死亡率相关,因此寻找这些综合征的早期生物标志物并制定新的预防和治疗策略至关重要。

相似文献

1
Vascular syndromes in liver cirrhosis.肝硬化中的血管综合征
Clin J Gastroenterol. 2019 Oct;12(5):387-397. doi: 10.1007/s12328-019-00956-0. Epub 2019 Apr 12.
2
Splanchnic and systemic vasodilatation: the patient.内脏和全身血管舒张:患者
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S266-71. doi: 10.1097/MCG.0b013e3181576d1a.
3
[Pulmonary complications of hepatic cirrhosis: portopulmonary hypertension and hepatopulmonary syndrome. The paradox of pulmonary vasoconstriction and vasodilation].肝硬化的肺部并发症:门脉高压性肺动脉高压和肝肺综合征。肺血管收缩与扩张的矛盾
Gac Med Mex. 2007 Jul-Aug;143(4):333-9.
4
Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.肝硬化中的内脏血管扩张和高动力循环综合征
World J Gastroenterol. 2014 Mar 14;20(10):2555-63. doi: 10.3748/wjg.v20.i10.2555.
5
Pathophysiological-based treatments of complications of cirrhosis.基于病理生理学的肝硬化并发症治疗方法。
Scand J Gastroenterol. 2020 Apr;55(4):383-394. doi: 10.1080/00365521.2020.1744709. Epub 2020 Apr 1.
6
Hemodynamic alterations in cirrhosis and portal hypertension.肝硬化和门静脉高压症中的血流动力学改变。
Korean J Hepatol. 2010 Dec;16(4):347-52. doi: 10.3350/kjhep.2010.16.4.347.
7
Pulmonary vascular disorders in portal hypertension.门静脉高压症中的肺血管疾病
Eur Respir J. 1998 May;11(5):1153-66. doi: 10.1183/09031936.98.11051153.
8
The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.肝硬化时动脉血管舒张和高动力循环的病理生理学。
Liver Int. 2018 Apr;38(4):570-580. doi: 10.1111/liv.13589. Epub 2018 Jan 15.
9
Complications of cirrhosis. A 50 years flashback.肝硬化的并发症。回顾50年历程。
Scand J Gastroenterol. 2015 Jun;50(6):763-80. doi: 10.3109/00365521.2015.1021709. Epub 2015 Apr 16.
10
Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications.
Acta Gastroenterol Belg. 1994 Mar-Apr;57(2):194-205.

引用本文的文献

1
Sustained effectiveness of balloon-occluded retrograde transvenous obliteration for portopulmonary hypertension after liver transplantation: a 5-year follow-up case report.肝移植术后球囊闭塞逆行经静脉栓塞术治疗门肺高压的持续有效性:一项5年随访病例报告
Clin J Gastroenterol. 2025 Sep 9. doi: 10.1007/s12328-025-02222-y.
2
From Pathophysiology to Practice: Evolving Pharmacological Therapies, Clinical Complications, and Pharmacogenetic Considerations in Portal Hypertension.从病理生理学到临床实践:门静脉高压症不断发展的药物治疗、临床并发症及药物遗传学考量
Metabolites. 2025 Jan 23;15(2):72. doi: 10.3390/metabo15020072.
3

本文引用的文献

1
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy.肝肾综合征的发病机制:治疗的启示。
Am J Kidney Dis. 2016 Feb;67(2):318-28. doi: 10.1053/j.ajkd.2015.09.013. Epub 2015 Oct 21.
2
Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.肝硬化失代偿和器官衰竭的机制:从外周动脉血管舒张到全身炎症假说。
J Hepatol. 2015 Nov;63(5):1272-84. doi: 10.1016/j.jhep.2015.07.004. Epub 2015 Jul 17.
3
Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study.
The Impact of Potent Addictive Substances on Angiogenic Behavior: A Comprehensive Review.
强效成瘾物质对血管生成行为的影响:一项综述
Curr Neuropharmacol. 2025;23(5):511-523. doi: 10.2174/1570159X23666240905125037.
4
Relationship between Circadian System Status, Child-Pugh Score, and Clinical Outcome in Cirrhotic Patients on Waiting Lists for Liver Transplantation.肝移植等待名单上肝硬化患者的昼夜节律系统状态、Child-Pugh评分与临床结局的关系
J Clin Med. 2024 Aug 2;13(15):4529. doi: 10.3390/jcm13154529.
5
Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine.肝脏疾病中的肝微循环障碍:中医药干预
Front Pharmacol. 2024 Jul 23;15:1399598. doi: 10.3389/fphar.2024.1399598. eCollection 2024.
6
Resolution of Severe Portopulmonary Hypertension With Inhaled Treprostinil and Liver Transplantation.经吸入用曲前列尼尔和肝移植治疗后,严重的门脉性肺动脉高压得到缓解。
Tex Heart Inst J. 2024 Mar 14;51(1). doi: 10.14503/THIJ-23-8209.
7
Portopulmonary Hypertension: An Updated Review.门肺高压:最新综述
Transplant Direct. 2023 Jul 21;9(8):e1517. doi: 10.1097/TXD.0000000000001517. eCollection 2023 Aug.
8
Current clinical understanding and effectiveness of portopulmonary hypertension treatment.门肺高压治疗的当前临床认识及疗效
Front Med (Lausanne). 2023 Apr 4;10:1142836. doi: 10.3389/fmed.2023.1142836. eCollection 2023.
9
Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry.日本多中心注册研究中门静脉高压性肺动脉高压患者的临床管理与预后
Circ Rep. 2022 Oct 8;4(11):542-549. doi: 10.1253/circrep.CR-22-0098. eCollection 2022 Nov 10.
10
Fractional Excretion of Sodium and Urea in Differentiating Acute Kidney Injury Phenotypes in Decompensated Cirrhosis.钠和尿素的分数排泄在鉴别失代偿期肝硬化急性肾损伤表型中的作用
J Clin Exp Hepatol. 2022 May-Jun;12(3):899-907. doi: 10.1016/j.jceh.2021.09.019. Epub 2021 Sep 28.
肝硬化患者非甾体类抗炎药相关的严重急性肾损伤:一项病例对照研究。
J Hepatol. 2015 Sep;63(3):593-600. doi: 10.1016/j.jhep.2015.04.004. Epub 2015 Apr 11.
4
Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.肝硬化和门静脉高压的肝外并发症:血流动力学和内稳态方面。
World J Gastroenterol. 2014 Nov 14;20(42):15499-517. doi: 10.3748/wjg.v20.i42.15499.
5
Renal dysfunction in cirrhosis is not just a vasomotor nephropathy.肝硬化中的肾功能障碍不仅仅是一种血管运动性肾病。
Kidney Int. 2015 Mar;87(3):509-15. doi: 10.1038/ki.2014.338. Epub 2014 Oct 8.
6
Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.慢性肝病和肝硬化中的血管病理生物学——现状与未来方向
J Hepatol. 2014 Oct;61(4):912-24. doi: 10.1016/j.jhep.2014.05.047. Epub 2014 Jun 6.
7
Cirrhosis and hepatopulmonary syndrome.肝硬化与肝肺综合征。
World J Gastroenterol. 2014 Mar 14;20(10):2586-94. doi: 10.3748/wjg.v20.i10.2586.
8
Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.肝硬化中的内脏血管扩张和高动力循环综合征
World J Gastroenterol. 2014 Mar 14;20(10):2555-63. doi: 10.3748/wjg.v20.i10.2555.
9
Management of portopulmonary hypertension: new perspectives.门静脉高压症的管理:新视角。
World J Gastroenterol. 2013 Dec 7;19(45):8252-7. doi: 10.3748/wjg.v19.i45.8252.
10
Cirrhotic cardiomyopathy: pathogenesis and clinical relevance.肝硬化性心肌病:发病机制与临床相关性。
Nat Rev Gastroenterol Hepatol. 2014 Mar;11(3):177-86. doi: 10.1038/nrgastro.2013.210. Epub 2013 Nov 12.